8-KLeadership ChangesExhibits & Filings

MORGAN STANLEY 8-K Report, Executive Changes (Jun 16, 2025)

Summary

Morgan Stanley announced a significant addition to its Board of Directors with the election of Lynn J. Good, former Chair, Chief Executive Officer, and President of Duke Energy Corporation. Ms. Good's appointment is effective July 18, 2025, and she has been deemed independent by the Board, aligning with the company's corporate governance standards. This strategic move brings a seasoned executive with extensive experience in a major utility sector to Morgan Stanley's leadership. Furthermore, Ms. Good will be a valuable member of the Board's Audit Committee, a critical function for oversight and governance in the financial services industry. Her compensation as a non-employee director will follow the established practices previously disclosed in the company's proxy statement. This appointment underscores Morgan Stanley's commitment to strong corporate governance and leveraging diverse expertise at the highest levels of the organization.

Key Highlights

  • 1Lynn J. Good, former CEO of Duke Energy, elected to Morgan Stanley's Board of Directors.
  • 2Appointment effective July 18, 2025.
  • 3Ms. Good has been determined to be independent by the Board.
  • 4Ms. Good will serve on the Board's Audit Committee.
  • 5Director compensation will be in line with the company's standard practices for non-employee directors.
  • 6The company is incorporating its press release regarding this appointment by reference.

Frequently Asked Questions

Lynn J. Good is the former Chair, Chief Executive Officer, and President of Duke Energy Corporation. Her extensive experience in leading a major utility company brings valuable executive leadership and industry perspective to Morgan Stanley's Board.

Ms. Good's election to the Board of Directors is effective July 18, 2025.

Upon her election, Ms. Good will join the Audit Committee of the Board.

Ms. Good will receive compensation as a non-employee director in accordance with Morgan Stanley's established practices, as detailed in the company's definitive proxy statement for its 2025 annual meeting.